Strides Shasun receives USFDA approval for Acetazolamide Tablets
Product to be launched in US immediately
Strides Shasun announced that its wholly owned subsidiary Strides Pharma Global has received approval from the USFDA for Acetazolamide Tablets USP, 125 mg and 250 mg, a generic version of Diamox Tablets. The product to be launched immediately will be marketed by Strides Pharma Inc. in the US market.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 22 2017 | 9:45 AM IST